Scribd Logo
Carica

Benvenuto in Scribd!

  • Tows GSK

    Caricato da

    Qanita Shah
    562 visualizzazioni2 pagine
    GSK has strengths in its strong brand image, large market share, extensive research and product range. However, it lacks online presence in Pakistan and over-focus on the UK market. It faces opportunities in expanding to developing countries and cashing in on its brand name in surgical markets. Threats include low-cost competition and patent expiries reducing income from major drugs. Strategies proposed to leverage R&D against competitors, maintain brand image post-patent losses, and expand beyond the UK market.

    Descrizione originale:

    TOWS Analaysis of GSK Pakistan

    Titolo originale

    TOWS GSK

    Copyright

    © © All Rights Reserved

    Formati disponibili

    DOCX, PDF, TXT o leggi online da Scribd

    Hai trovato utile questo documento?

    Questo contenuto è inappropriato?

    Segnala questo documento
    GSK has strengths in its strong brand image, large market share, extensive research and product range. However, it lacks online presence in Pakistan and over-focus on the UK market. It faces opportunities in expanding to developing countries and cashing in on its brand name in surgical markets. Threats include low-cost competition and patent expiries reducing income from major drugs. Strategies proposed to leverage R&D against competitors, maintain brand image post-patent losses, and expand beyond the UK market.

    Copyright:

    © All Rights Reserved
    Scarica in formato DOCX, PDF, TXT o leggi online su Scribd
    Segnala contenuti inappropriati
    562 visualizzazioni2 pagine

    Tows GSK

    Caricato da

    Qanita Shah
    GSK has strengths in its strong brand image, large market share, extensive research and product range. However, it lacks online presence in Pakistan and over-focus on the UK market. It faces opportunities in expanding to developing countries and cashing in on its brand name in surgical markets. Threats include low-cost competition and patent expiries reducing income from major drugs. Strategies proposed to leverage R&D against competitors, maintain brand image post-patent losses, and expand beyond the UK market.

    Copyright:

    © All Rights Reserved
    Scarica in formato DOCX, PDF, TXT o leggi online su Scribd
    Segnala contenuti inappropriati
    di 2

    T.O.W.

    S Matrix of GSK Company

    Strengths WEAKNESSES
    S1: Strong brand image and W1: No online presence in
    management team. Pakistan
    S2: Largest market share W2: Strong focus on UK
    S3: Highest research products market losing opportunities in
    and large R&D. other market
    S4: Wide range of product W3: Representation for their
    working in field
    W4: Block basters products
    expose to generic
    competition and reaching
    maturity

    OPPORTUNITIES SO: Strategies WO: Strategies


    O1: Expansion in developing S3O2: Have great chance to W2O1: Expansion in
    Countries cash its brand name in developing market or
    O2: Have great chance to swgical field with the help of countries will divert their
    cash its brand name in the its largest R&D focus from UK market to
    field of swgical market. S4O1: With the help of wide other market
    range of products , imagen W4O1: Block buster
    GSK can expend in products expose to generic
    developing countries competition and reaching
    maturity thus in order to grow
    the sales, GSK can enter into
    surgical field.

    THREATS ST Strategies WT strategies


    T1: Low cost competition S3T1: Leverage use of R&D W4T2: Relaunch the patent
    like imports like Chinese, and strong management expired product with some
    Indian medicines etc. To compete lower cost modification to beat
    T2: Patent expiry on drugs competition competition.
    that generate strong 'incom' S1T2 : with the help of W1T1: Use promotional and
    strong brand image in patients marketing expenditure to face
    and doctors mind it would the lowest cost competitive
    retain its most of equal even products
    after the loss of product
    SWOT

    Strengths WEAKNESSES

    S1: Strong brand image and management team. W1: No online presence in Pakistan
    S2: Largest market share W2: Strong focus on UK market losing
    S3: Highest research products and large R&D. opportunities in other market
    S4: Wide range of product W3: Representation for their working in field
    W4: Block basters products
    expose to generic competition and reaching
    maturity
    OPPORTUNITIES THREATS

    O1: Expansion in developing T1: Low cost competition like imports like
    Countries Chinese, Indian medicines etc.
    O2: Have great chance to cash its brand name T2: Patent expiry on drugs that generate
    in the field of swgical market strong 'incom'

    Potrebbero piacerti anche